Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Jun 13;18(1):251.
doi: 10.1007/s11701-024-01930-w.

Cost analysis of new robotic competitors: a comparison of direct costs for initial hospital stay between Da Vinci and Hugo RAS for radical prostatectomy

Maria Chiara Sighinolfi  1 , Luigi Amerigo Messina  2 , Matteo Stocco  2   3 , Marcio Covas Moscovas  4 , Paolo Pelliccia  2 , Alessia Palma  2 , Marta Rossini  2 , Angela Gallo  2 , Augusto Ramondo  5 , Efrem Pozzi  5 , Simone Assumma  5 , Stefano Terzoni  5 , Marco Sandri  4   6 , Vipul Patel  4 , Bernardo Rocco  5   3
Affiliations
Comparative Study

Cost analysis of new robotic competitors: a comparison of direct costs for initial hospital stay between Da Vinci and Hugo RAS for radical prostatectomy

Maria Chiara Sighinolfi et al. J Robot Surg. .

Abstract

Robotic surgery with Da Vinci has revolutionized the treatment of several diseases, including prostate cancer; nevertheless, costs remain the major drawback. Recently, new robotic platforms entered the market aiming to reduce costs and improve the access to robotic surgery. The aim of the study is to compare direct cost for initial hospital stay of radical prostatectomy performed with two different robotic systems, the Da Vinci and the new Hugo RAS system. This is a projection study that applies cost of robotic surgery, derived from a local tender, to the clinical course of robotic radical prostatectomy (RALP) performed with Da Vinci and Hugo RAS. The study was performed in a public referral center for robotic surgery equipped with both systems. The cost of robotic surgery from a local tender were considered and included rent, annual maintenance, and a per-procedure fee covering the setup of four robotic instruments. Those costs were applied to patients who underwent RALP with both systems since November 2022. The primary endpoint is to evaluate direct costs of initial hospital stay for Da Vinci and Hugo RAS, by considering equipment costs (as derived from the tender), and costs of theater and of hospitalization. The direct per-procedure cost is €2,246.31 for a Da Vinci procedure and €1995 for a Hugo RALP. In the local setting, Hugo RAS provides 11% of cost saving for RALP. By applying this per-procedure cost to our clinical data, the expenditure for the entire index hospitalization is € 6.7755,1 for Da Vinci and € 6.637,15 for Hugo RALP. The new Hugo RAS system is willing to reduce direct expenditures of robotic surgery for RALP; furthermore, it provides similar peri-operative outcomes compared to the Da Vinci. However, other drivers of costs should be taken into account, such as the duration of OR use-that is more than just console time and may depend on the facility's background and organization. Further variations in direct costs of robotic systems are related to caseload, local agreements and negotiations. Thus, cost comparison of new robotic platform still remains an ongoing issue.

Keywords: Cost analysis; Direct costs; Economics; New robotic systems; Robotic surgery.

PubMed Disclaimer

References

    1. Sadri H, Fung-Kee-Fung M, Shayegan B, Garneau PY, Pezeshki P (2023) A systematic review of full economic evaluations of robotic-assisted surgery in thoracic and abdominopelvic procedures. J Robot Surg. https://doi.org/10.1007/s11701-023-01731-7 - DOI - PubMed - PMC
    1. Bravi CA, Paciotti M, Balestrazzi E, Piro A, Piramide F, Peraire M, Sarchi L, Mottaran A, Nocera L, De Backer P, De Naeyer G, D’Hondt F, De Groote R, Mottrie A (2023) Outcomes of robot-assisted radical prostatectomy with the hugo RAS surgical system: initial experience at a high-volume robotic center. Eur Urol Focus 9(4):642–644. https://doi.org/10.1016/j.euf.2023.01.008 - DOI - PubMed
    1. Ragavan N, Bharathkumar S, Chirravur P, Sankaran S (2023) Robot-assisted laparoscopic radical prostatectomy utilizing Hugo RAS platform: initial experience. J Endourol 37:147–150 - DOI - PubMed
    1. Bravi CA, Balestrazzi E, De Loof M, Rebuffo S, Piramide F, Mottaran A, Paciotti M, Sorce G, Nocera L, Sarchi L, Peraire M, Colla’-Ruvolo C, Frego N, Piro A, Ticonosco M, De Backer P, Farinha R, Van Den Bossche H, De Naeyer G, D’Hondt F, De Groote R, Mottrie A (2023) Robot-assisted radical prostatectomy performed with different robotic platforms: first comparative evidence between da vinci and hugo robot-assisted surgery robots. Eur Urol Focus. https://doi.org/10.1016/j.euf.2023.08.001 - DOI - PubMed
    1. Ploussard G, Grabia A, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Lequeu CE; CC-AFU, Cancerology Committee of the Association Française d’Urologie (2022) Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic). World J Urol. https://doi.org/10.1007/s00345-021-03878-0 - DOI

Publication types

MeSH terms

LinkOut - more resources